THYPINONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Thypinone, and when can generic versions of Thypinone launch?
Thypinone is a drug marketed by Abbott and is included in one NDA.
The generic ingredient in THYPINONE is protirelin. There are four drug master file entries for this compound. Additional details are available on the protirelin profile page.
Summary for THYPINONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Patent Applications: | 3,351 |
DailyMed Link: | THYPINONE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for THYPINONE
US Patents and Regulatory Information for THYPINONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | THYPINONE | protirelin | INJECTABLE;INJECTION | 017638-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for THYPINONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | THYPINONE | protirelin | INJECTABLE;INJECTION | 017638-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for THYPINONE
See the table below for patents covering THYPINONE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 2018870 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |